News News Select Year All Years 2026 (24) 2025 (34) 2024 (29) 2023 (30) 2022 (33) 2021 (27) 2020 (34) 2019 (32) 2018 (42) 2017 (35) 2016 (43) 2015 (53) 2014 (26) 2013 (21) 2012 (16) 2011 (6) 2010 (4) 2009 (5) 2007 (1) 2006 (1) Search News Found 496 Results Page 43 of 50« First«...102030...4142434445...50...»Last » October 14, 2014 DBV Technologies Announces Topline Financial Results for First Nine Months 2014 September 22, 2014 DBV Technologies Announces Primary Endpoint Met in VIPES, Viaskin Peanut’s Phase IIb Clinical Trial in Peanut Allergy August 26, 2014 DBV Technologies to Attend the Goldman Sachs European Biotech Symposium July 28, 2014 DBV Technologies Reports Financial Results for the First Six Months of 2014 July 17, 2014 Consortium of Food Allergy Research Completes Recruitment of NIH-sponsored CoFar6 Phase II Trial with DBV’s Viaskin® Peanut in Treatment of Peanut Allergy July 17, 2014 DBV Technologies Completes last “food challenge” visit of last Peanut-Allergic patient in VIPES Phase IIb Clinical Study June 16, 2014 DBV Technologies to Present at Upcoming US Investors Conferences June 10, 2014 Five Scientific Communications at the European Academy of Allergy and Clinical Immunology Congress Further Support DBV’s EPITTM Disease Modifying Effect May 13, 2014 DBV Technologies Announces Clinical Trial Agreement to Develop a Treatment for Milk-Induced Eosinophilic Esophagitis in Children May 12, 2014 DBV Technologies to Host and Webcast Investor Day in New York City on May 21, 2014 Page 43 of 50« First«...102030...4142434445...50...»Last »
